II Consensus of the Brazilian Society of Dermatology for the treatment of alopecia areata
Treatments vary according to patient age and disease severity. Intralesional injectable corticosteroid therapy was considered the first option for localized disease in adults. In severe cases, Janus Kinase inhibitors are the treatment with the highest level of evidence. Systemic corticosteroid therapy and immunosuppressants (corticosteroid-sparing agents) are also options in these cases. Contact immunotherapy (diphencyprone) is an alternative for stable extensive cases. The assessment of side effects is as important as the hair regrowth rate.
Authors
- Lorena Dourado Alves (ORCID: https://orcid.org/0000-0002-3502-7102)
- Alessandra Anzai (ORCID: https://orcid.org/0000-0002-6608-7757)
- Fabiane Mulinari‐Brenner (ORCID: https://orcid.org/0000-0001-7970-522X)
- Paulo Müller Ramos (ORCID: https://orcid.org/0000-0002-1561-414X)
- Flavia Sternberg (ORCID: https://orcid.org/0000-0002-6498-8535)
- Leopoldo Duailibe Nogueira Santos
- Bruna Duque‐Estrada (ORCID: https://orcid.org/0000-0002-8540-3049)
- Daniel Fernandes Melo (ORCID: https://orcid.org/0000-0002-8807-2556)
Institutions
- Universidade de Taubaté (BR)
- Universidade de São Paulo (BR)
- Universidade do Estado do Rio de Janeiro (BR)
- Hospital do Servidor Público Municipal (BR)
- Institute of Dermatology (TH)
- Universidade Federal do Paraná (BR)
- Universidade Federal de Goiás (BR)
- Universidade Estadual Paulista (Unesp) (BR)
- Universidade Federal de São Paulo (BR)
Publication Details
- Journal
- Anais Brasileiros de Dermatologia
- Published
- 2024-12-04
- DOI
- https://doi.org/10.1016/j.abd.2024.10.001
- Citations
- 6
- Primary Topic
- Hair Growth and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 3.21